Yes oldngrey, CVac has been developed as a platform drug to treat a number of cancers (breast, ovarian, prostate, lung and colon).
The early steps of extending the research to other indiactions will be confirming the method of action in the ICS data that's about to be released.
Ovarian is the first cab off the rank due to its unmet need; so is the softer target in terms of approvals.
strong support, page-15
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 296 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 116 | 1 |
View Market Depth
| Last trade - 09.36am 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable